quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:00:00·198d
PRRelease
enGene Therapeutics Inc. logo
GT Biopharma Inc. logo
I-MAB logo
+2

Novel Cancer Platforms Converge as Clinical Data Reshapes Treatment Paradigms

ENGN· enGene Therapeutics Inc.GTBP· GT Biopharma Inc.IMAB· I-MABNBTX· Nanobiotix S.A.ONCO· Onconetix Inc.
Health Care
Original source

Companies

  • ENGN
    enGene Therapeutics Inc.
    Health Care
  • GTBP
    GT Biopharma Inc.
    Health Care
  • IMAB
    I-MAB
    Health Care
  • NBTX
    Nanobiotix S.A.
    Health Care
  • ONCO
    Onconetix Inc.
    Health Care

Recent analyst ratings

  • Apr 13ENGNUpdateWBB Securities$21.50
  • Feb 6NBTXUpdateTD Cowen-
  • Jan 30ENGNUpdateJefferies$28.00
  • Nov 11ENGNUpdateRaymond James$27.00
  • Oct 3IMABUpdateLeerink Partners$9.00
  • Sep 9IMABUpdateBTIG Research$7.00

Related

  • INSIDER1d
    SEC Form 4 filed by Hrt Financial Lp
  • INSIDER2d
    SEC Form 4 filed by Hrt Financial Lp
  • SEC3d
    SEC Form 6-K filed by Nanobiotix S.A.
  • PR3d
    Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer Technology
  • INSIDER7d
    SEC Form 4 filed by Hrt Financial Lp
  • INSIDER7d
    SEC Form 3 filed by new insider Hrt Financial Lp
  • ANALYST10d
    WBB Securities initiated coverage on enGene Therapeutics with a new price target
  • SEC14d
    enGene Therapeutics Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022